文献
J-GLOBAL ID:201802252294190558
整理番号:18A0354207
ジェランガムとカッパ-カラジーナンに基づく新しいイオン感応ヒドロゲルの高分解能シンチグラフィーによるin vivoでの眼表面居住定量【Powered by NICT】
In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan
著者 (31件):
Fernandez-Ferreiro Anxo
(Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
,
Fernandez-Ferreiro Anxo
(Pharmacy Department, Xerencia de Xestion Integrada de Santiago de Compostela (SERGAS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Fernandez-Ferreiro Anxo
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Fernandez-Ferreiro Anxo
(Clinical Pharmacology Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Silva-Rodriguez Jesus
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Otero-Espinar Francisco Javier
(Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
,
Gonzalez-Barcia Miguel
(Pharmacy Department, Xerencia de Xestion Integrada de Santiago de Compostela (SERGAS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Gonzalez-Barcia Miguel
(Clinical Pharmacology Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Lamas Maria Jesus
(Pharmacy Department, Xerencia de Xestion Integrada de Santiago de Compostela (SERGAS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Lamas Maria Jesus
(Clinical Pharmacology Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Ruibal Alvaro
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Ruibal Alvaro
(Nuclear Medicine Department, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Ruibal Alvaro
(Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
,
Ruibal Alvaro
(Fundacion Tejerina, Madrid 28003, Spain)
,
Luaces-Rodriguez Andrea
(Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
,
Vieites-Prado Alba
(Clinical Neurosciences Research Laboratory, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Lema Isabel
(Clinical Neurosciences Research Laboratory, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Herranz Michel
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Herranz Michel
(Nuclear Medicine Department, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Gomez-Lado Noemi
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Blanco-Mendez Jose
(Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
,
Gil-Martinez Maria
(Ophthalmology Department, Xerencia de Xestion Integrada de Santiago de Compostela (SERGAS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Pardo Maria
(Obesidomic Group, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Moscoso Alexis
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Cortes Julia
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Cortes Julia
(Nuclear Medicine Department, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Sanchez-Martinez Maria
(Galician PET Radiopharmacy Unit, Galaria, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Pardo-Montero Juan
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Pardo-Montero Juan
(Medical Physics Department, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Travesia Choupana s/n, Santiago de Compostela 15706, Spain)
,
Aguiar Pablo
(Molecular Imaging Group, University Clinical Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Travesia da Choupana s/n, Santiago de Compostela 15706, Spain)
,
Aguiar Pablo
(Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain)
資料名:
European Journal of Pharmaceutics and Biopharmaceutics
(European Journal of Pharmaceutics and Biopharmaceutics)
巻:
114
ページ:
317-323
発行年:
2017年
JST資料番号:
B0129B
ISSN:
0939-6411
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)